Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
6
×
fda
6
×
life sciences
national blog main
new york blog main
san diego blog main
san diego top stories
6
×
boston blog main
boston top stories
clinical trials
national top stories
new york top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
eli lilly
investing
pfizer
startups
abbvie
astrazeneca
bristol-myers squibb
cancer immunotherapy
deals
What
drug
6
×
fda
approved
bio
companies
disease
europe
make
medicine
new
roundup
year
alnylam
alzheimer’s
annual
approval
approves
arguments
assessed
attention
bacteria
big
biopharma
biotech
business
cancer
cells
class
commercialized
communities
company
competitors
conference
decades
deeper
digital
dna
drugs
ema
employ
Language
Current search:
fda
×
drug
×
drugs
×
" san diego top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug